Several reports suggest that IL-10 can inhibit antigen presentation and downregulate the formation and secretion of IL-1, IL-6, TNF-α, and other critical inflammatory aspects in macrophages and T cells, thus improving IBD intestinal inflammation [32,33,34]. Here, IL6 is linked to inflammatory bowel disease.